Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes

NCT00223067 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplantation

Interventions

DRUG: TAIZ

Sponsor

University Hospital Schleswig-Holstein